Updated results from a phase I/II study of mobocertinib (TAK788) in NSCLC with EGFR exon 20 insertions (exon20ins) Meeting Abstract


Authors: Riely, G. J.; Neal, J. W.; Camidge, D. R.; Spira, A.; Piotrowska, Z.; Horn, L.; Costa, D. B.; Tsao, A.; Patel, J.; Gadgeel, S.; Bazhenova, L.; Zhu, V. W.; West, H.; Mekhail, T.; Gentzler, R.; Nguyen, D.; Bunn, V.; Jin, S.; Feng, Z.; Jänne, P. A.
Abstract Title: Updated results from a phase I/II study of mobocertinib (TAK788) in NSCLC with EGFR exon 20 insertions (exon20ins)
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S815
End Page: S816
Language: English
ACCESSION: WOS:000573469101547
DOI: 10.1016/j.annonc.2020.08.1575
PROVIDER: wos
Notes: Meeting Abstract: 1261MO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely